Medicure Pharma Inc.
$47.8K 304 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Eclipse Technology Solutions Inc.
Eclipse Technology Solutions Inc. reported $47,660.91 across General Payments, Research, and Ownership to 552 physicians and teaching hospitals across 552 transactions.
- $47.7K
- All-tracks total
- 552
- Transactions
- 552
- Recipients
- +$16.5K
- General Payments vs PY2023
Eclipse Technology Solutions Inc. reported $47,660.91 across all CMS Open Payments tracks (General + Research + Ownership) to 552 physicians and teaching hospitals in Program Year 2024 - ranking #1363 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $47,660.91, averaging $86.34 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer eclipse-technology-solutions-inc Eclipse Technology Solutions Inc.
$47.7K · #1363/1,925 · 0.0% industry · PY2024
- TOT $47.7K
- RANK #1363
- SHARE 0.0%
- TXN 552
- RCP 552
- CAT 2
- GEN $47.7K
- ΔGEN +$16.5K
- TOP1 7.1%
- PY 2024
Volume peers
Nearest volume peer: Medicure Pharma Inc. ($47.8K)
Eclipse Technology Solutions Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Eclipse Technology Solutions Inc.'s CMS-reported General Payments increased by $16.5K (+53.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: ECLIPSE TECHNOLOGY SOLUTIONS INC.PY2023: ECLIPSE TECHNOLOGY SOLUTIONS INC.PY2024: Eclipse Technology Solutions Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $31,135.60
- PY2024
- $47,660.91
What the Data Shows for Eclipse Technology Solutions Inc.
Rank #1363 of 1,925 companies in CMS Open Payments for 2024 belongs to Eclipse Technology Solutions Inc., which reported $47,660.91 across 552 transactions to 552 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $86.34 per transaction and $86.34 per recipient.
Of the 2 general-payment categories charted below, "Food and Beverage" is the largest at $24.9K across 454 transactions, 52.2% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Eclipse Technology Solutions Inc. made 2 types of general payments. "Food and Beverage" is the largest category at $24.9K, 52.2% of General Payments.
How Eclipse Technology Solutions Inc. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $24.9K | 454 | 52.2% |
| Travel and Lodging | $22.8K | 98 | 47.8% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $10,627.80 (22.3%) of $47,660.91 in this company's General Payments records across 242 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Eclipse Technology Solutions Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Andrew Mostello
$3,377.69 across 15 reported transactions
- 2
Edward Appelbaum
$2,147.87 across 10 reported transactions
- 3
Jeffrey Murray
$2,136.79 across 10 reported transactions
- 4
Spencer Monaco
$1,543.90 across 10 reported transactions
- 5
Jeremie Axe
$1,421.55 across 17 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Eclipse Technology Solutions Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Eclipse Technology Solutions Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Eclipse Technology Solutions Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
United Orthopedics LLC
$47.9K 226 recipients
Compare payment profiles
The Walman Optical Company
$47.1K 29 recipients
Compare payment profiles
Aspen Surgical Products, Inc.
$47.1K 7 recipients
Compare payment profiles
Activ Surgical, Inc.
$48.3K 91 recipients
Compare payment profiles
EMD Millipore Corporation
$47.0K 6 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.